David Veitch
Chief Executive Officer bij BASILEA PHARMACEUTICA AG
Vermogen: 54 341 $ op 31-03-2024
Actieve functies van David Veitch
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BASILEA PHARMACEUTICA AG | Chief Executive Officer | 19-04-2018 | - |
| Corporate Officer/Principal | 01-09-2014 | 19-04-2018 |
Loopbaan van David Veitch
Eerdere bekende functies van David Veitch
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SAVIENT PHARMACEUTICALS INC | Corporate Officer/Principal | 01-01-2012 | 01-01-2013 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | 01-01-2004 | 01-01-2011 |
Opleiding van David Veitch
| University of Bristol | Undergraduate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
| Verenigde Staten | 2 |
| Zwitserland | 2 |
Operationeel
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BASILEA PHARMACEUTICA AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
- Beurs
- Insiders
- David Veitch
- Ervaring
